Covidien Limited (COV)

SHARE
TEXT SIZE:
SHARE
Send a copy to me

Separate multiple email addresses (max 20) with commas.

0/1500
Richard J. Meelia , CEO/Director/President
Industry: Healthcare
OPEN
LAST
$
PREV CLOSE
CHANGE
VOLUME


Overview
News
People
Financials

Company Information

Richard J. Meelia, CEO/Director/President

131 Front Street

Hamilton

, HM 12

BU Map it

Phone: (441) 298-2480

Fax:

www.covidien.com

Latest news from Portfolio


Overview

The Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings.

Portfolio Articles
  • Have a Seat
    Ever since Enron's downfall and the introduction of Sarbanes-Oxley, corporate boards have taken on a less clubby air -- presenting opportunities for first-timers.
    May 02 2008

See more news on this company

News From Around the Web
powered by  inform

Employees

Number of Employees: 43,800
Revenue per Employee: $232,192

Top Executives

Kevin G. DaSilva, Director/Vice President/Treasurer
John H. Masterson, Director/General Counsel/Senior VP
Jose E. Almeida, Senior VP/President, Divisional

Charles J. Dockendorff, Executive VP/CFO/Director
Richard G. Brown, Jr., Chief Accounting Officer/Vice President/Controller
Karen A. Quinn-Quintin, Senior VP, Divisional

Amy A. McBride-Wendell, Senior VP, Divisional
Timothy R. Wright, President, Divisional/Senior VP
Eric C. Green, Vice President/Other Executive Officer

Coleman N. Lannum, Vice President, Divisional
Eric A. Kraus, Senior VP, Divisional

Board of Directors

Kevin G. DaSilva, Director/Vice President/Treasurer
Craig Arnold, Director
Dennis H. Reilley, Chairman of the Board/Director

Timothy M. Donahue, Director
Robert H. Brust, Director
Kathy J. Herbert, Director

Randall J. Hogan, Director
Eric C. Green, Vice President/Other Executive Officer

John H. Masterson, Director/General Counsel/Senior VP

Charles J. Dockendorff, Executive VP/CFO/Director

Financials

Quarterly
Annual

Income Statement 08/2008 05/2008 02/2008 12/2007
Sales 1.2 Bil. 1.06 Bil. 1.08 Bil. 1.22 Bil.
Gross Operating Profit 1.39 Bil. 1.37 Bil. 1.24 Bil. 1.39 Bil.
Operating Income before D & A (EBITDA) 559 Mil. 596 Mil. 472 Mil. 612 Mil.
Total Income Before Interest Expenses (EBIT) 552 Mil. 416 Mil. 647 Mil. 179 Mil.
Total Net Income 393 Mil. 235 Mil. 470 Mil. 34 Mil.
Basic EPS, Total 0.78 0.47 0.94 0.07
Diluted EPS, Total 0.77 0.46 0.94 0.07

BALANCE STATEMENT 08/2008 05/2008 02/2008 12/2007
Cash and Equivalents NA 849 Mil. NA 872 Mil.
Total Assets NA 5.37 Bil. NA 7.56 Bil.
Total Liabilities NA 2 Bil. NA 5.37 Bil.
Total Capitalization NA 10.99 Bil. NA 10.31 Bil.

Cash Flow 08/2008 05/2008 02/2008 12/2007
Net Cash From Continuing Operations NA -462 Mil. NA 2.2 Bil.
Net Cash From Investing Activities NA 992 Mil. NA -1.71 Bil.
Net Cash From Financing Activities NA -627 Mil. NA 110 Mil.
Net Change in Cash & Cash Equivalents NA -23 Mil. NA 630 Mil.

powered by Interactive Data

Income Statement 2007
Sales 4.92 Bil.
Gross Operating Profit 5.25 Bil.
Operating Income before D & A (EBITDA) 2.44 Bil.
Total Income Before Interest Expenses (EBIT) 339 Mil.
Total Net Income -332 Mil.
Basic EPS, Total -0.67
Diluted EPS, Total -0.67

BALANCE STATEMENT 2007
Cash and Equivalents 872 Mil.
Total Assets 7.56 Bil.
Total Liabilities 5.37 Bil.
Total Capitalization 10.31 Bil.

Cash Flow 2007
Net Cash From Continuing Operations 2.2 Bil.
Net Cash From Investing Activities -1.71 Bil.
Net Cash From Financing Activities 110 Mil.
Net Change in Cash & Cash Equivalents 630 Mil.

powered by Interactive Data







Related Companies by Market Cap
Company Name
Price
Change
Market Cap
21.14 Bil.
17.65 Bil.
27.26 Bil.
9.34 Bil.

Company Profile Change Request

The data provided in our company profiles comes from third party information providers.

Also in Portfolio.com
Most Read
Most Emailed
Recently Commented